arrow
返回

Bayesian unsupervised clustering identifies clinically relevant osteosarcoma subtypes

delete2024-12-20
delete0
delete
OA
AI
S
Sergio Llaneza‐Lago
W
William D. Fraser
D
Darrell Green *
DOI:10.1093/bib/bbae665delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Identification of cancer subtypes is a critical step for developing precision medicine. Most cancer subtyping is based on the analysis of RNA sequencing (RNA-seq) data from patient cohorts using unsupervised machine learning methods such as hierarchical cluster analysis, but these computational approaches disregard the heterogeneous composition of individual cancer samples. Here, we used a more sophisticated unsupervised Bayesian model termed latent process decomposition (LPD), which handles individual cancer sample heterogeneity and deconvolutes the structure of transcriptome data to provide clinically relevant information. The work was performed on the pediatric tumor osteosarcoma, which is a prototypical model for a rare and heterogeneous cancer. The LPD model detected three osteosarcoma subtypes. The subtype with the poorest prognosis was validated using independent patient datasets. This new stratification framework will be important for more accurate diagnostic labeling, expediting precision medicine, and improving clinical trial success. Our results emphasize the importance of using more sophisticated machine learning approaches (and for teaching deep learning and artificial intelligence) for RNA-seq data analysis, which may assist drug targeting and clinical management.
Keyword:
heterogeneity
latent process decomposition
osteosarcoma
precision medicine
RNA-seq
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Briefings in Bioinformatics 封面图
Briefings in Bioinformatics
IF:
7.7
论文数:
5.8K
被引数:
2.7W

机构

暂无机构信息
引用论文

引用论文

err分享
err收藏
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children?s Oncology Group复发性骨肉瘤患者抗对话神经节苷脂抗体dinutuximab联合gm-csf的2期研究: 儿童肿瘤学小组的报告
err2022-09-01
err17
errOAAI
errHingorani, Pooja; Krailo, Mark; Buxton, Allen; Hutson, Paul; Sondel, Paul M.; Diccianni, Mitchell; Yu, Alice; Morris, Carol D.; Womer, Richard B.; Crompton, Brian; Randall, R. Lor; Teot, Lisa A.; DuBois, Steven G.; Janeway, Katherine A.; Gorlick, Richard G.; Isakoff, Michael S.
err分享
err收藏
Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma
err2018-01-15
err92
errOAAI
errScott, Milcah C.; Temiz, Nuri A.; Sarver, Anne E.; LaRue, Rebecca S.; Rathe, Susan K.; Varshney, Jyotika; Wolf, Natalie K.; Moriarity, Branden S.; O'Brien, Timothy D.; Spector, Logan G.; Largaespada, David A.; Modiano, Jaime F.; Subramanian, Subbaya; Sarver, Aaron L.
err分享
err收藏
A Bayesian model for unsupervised detection of RNA splicing based subtypes in cancers
err2023-01-04
err5
errOAAI
errWang, David; Quesnel-Vallieres, Mathieu; Jewell, San; Elzubeir, Moein; Lynch, Kristen; Thomas-Tikhonenko, Andrei; Barash, Yoseph
err分享
err收藏
err
IF0
err
err0
PREAI
err
err分享
err收藏
The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies
err2021-05-25
err12
errOAAI
errKovac, Michal; Ameline, Baptiste; Ribi, Sebastian; Kovacova, Monika; Cross, William; Barenboim, Maxim; Witt, Olaf; Bielack, Stefan; Krieg, Andreas; Hartmann, Wolfgang; Nathrath, Michaela; Baumhoer, Daniel
err分享
err收藏
Recurrent Somatic Structural Variations Contribute to Tumorigenesis in Pediatric Osteosarcoma
err2014-04-01
err597
errOAAI
errChen, Xiang; Bahrami, Armita; Pappo, Alberto; Easton, John; Dalton, James; Hedlund, Erin; Ellison, David; Shurtleff, Sheila; Wu, Gang; Wei, Lei; Parker, Matthew; Rusch, Michael; Nagahawatte, Panduka; Wu, Jianrong; Mao, Shenghua; Boggs, Kristy; Mulder, Heather; Yergeau, Donald; Lu, Charles; Ding, Li; Edmonson, Michael; Qu, Chunxu; Wang, Jianmin; Li, Yongjin; Navid, Fariba; Daw, Najat C.; Mardis, Elaine R.; Wilson, Richard K.; Downing, James R.; Zhang, Jinghui; Dyer, Michael A.
err分享
err收藏
Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma
errCANCER
IF5.1
err2003-06-12
err85
PREAI
errLaverdiere, C; Kolb, EA; Supko, JG; Gorlick, R; Meyers, PA; Maki, RG; Wexler, L; Demetri, GD; Healey, JH; Huvos, AG; Goorin, AM; Bagatell, R; Ruiz-Casado, A; Guzman, C; Jimeno, J; Harmon, D
err分享
err收藏
err分享
err收藏
err分享
err收藏
学者 查看更多内容